For a blood-borne cancer therapeutic agent to be effective, it must cross the blood vessel
wall to reach cancer cells in adequate quantities, and it must overcome the resistance …

Molecular imaging has experienced enormous advancements in the areas of imaging
technology, imaging probe and contrast development, and data quality, as well as machine …

The near‐infrared window between 1000 and 1700 nm, commonly termed the “second near‐
infrared (NIR‐II) window,” has quickly emerged as a highly attractive optical region for …

These joint practice guidelines, or procedure standards, were developed collaboratively by
the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and …

Brain tumor is one of the most lethal cancers owing to the existence of blood–brain barrier
and blood–brain tumor barrier as well as the lack of highly effective brain tumor treatment …

Precise diagnostics are of significant importance to the optimal treatment outcomes of
patients bearing brain tumors. NIR‐II fluorescence imaging holds great promise for brain …

The management of patients with glioma usually requires multimodality treatment including
surgery, radiotherapy, and systemic therapy. Accurate neuroimaging plays a central role for …

Diagnostics of cerebrovascular structures and microscopic tumors with intact blood–brain
barrier (BBB) significantly contributes to timely treatment of patients bearing neurological …

Senescence refers to a cellular state featuring a stable cell‐cycle arrest triggered in
response to stress. This response also involves other distinct morphological and intracellular …

Brain metastases (BM) from extracranial cancer are associated with significant morbidity and
mortality. Effective local treatment options are stereotactic radiotherapy, including …